The largest database of trusted experimental protocols

13 protocols using pcdna5 frt to plasmid

1

Programmable Transcriptional Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A repeat-variable di-residue (RVD) domain specifically targeting the 5′-CTCTGCGCCTGCGCCGGCGC-3′ sequence within the 29 bp repeat consensus sequence was designed using TAL Effector Targeter46 (link). Variable numbers of the target 20 bp sequence are identified within the most distal 3 kb of 20 subtelomeres according to a complete clone-based assembly of human subtelomeric regions47 (link). A 3560 bp DNA fragment corresponding to a full TALE module comprising the designed RVD followed by an SV40 nuclear localization signal and a human influenza hemagglutinin (HA) tag was synthesized at GenScript. The fragment was cloned into a KpnI/ApaI digested pcDNA5-FRT-TO plasmid (ThermoFisher Scientific) downstream of a doxycycline-inducible CMV promoter (unfused T-TALE). The obtained plasmid was digested with ClaI and EcoRV and ligated to a 429 bp fragment comprising the Enhanced Repressor Domain and synthesized at GenScript (SID4X T-TALE). Plasmid sequences are available upon request.
+ Open protocol
+ Expand
2

Generation of CDK11 Expression Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid containing human CDK11 (GenBank Accesion number: AAC72077) was obtained from Dr. J. Lahti lab (Memphis, Tennessee). CDK11 cDNA was sub-cloned into HindIII and XhoI restriction sites of doxycycline inducible pcDNA5/FRT/TO plasmid (Thermo Fisher Scientific) in frame with 5’flag or 5’myc tag. CDK11 deletion mutants were prepared using QuikChange II XL Site-Directed Mutagenesis Kit (Agilent, #200522) according to the manufacturer´s protocol. Primers for the mutagenesis were designed to flank the region to be deleted.
Complete list of plasmids used in the study is in the Supplementary Table 8
+ Open protocol
+ Expand
3

CRISPR Plasmid Construction for TDRD3 and TOP3B

Check if the same lab product or an alternative is used in the 5 most similar protocols
To construct CRISPR editing plasmids targeting TDRD3 (pX330-TDRD gRNA1, pX330-TDRD gRNA1) or TOP3B gene (px330-TOP3B gRNA1, pX330-TDRD gRNA2), oligo sequences provided upon request, were purchased from IDT and were sub-cloned into pX330 as described previously20 (link). To generate pFLAG-TOP3B, human Full-length Top3B with FLAG-Tag sequence was amplified using the following set of primers: forward (5′- CCCAAGCTTATGGATTACAAGGATGACGACGATAAGAAGACTGTGCTCATGGTTGCTGAA-3′) and reverse (5′- CGCGGATCCTCATACAAAGTAGGCGGCCAGGGCTGACAT −3′). And the amplicon sequence was sub-cloned into pcDNA5/FRT/TO plasmid (Thermo Fisher Scientific). Plasmids GFP-tagged full length TDRD3 (pGFP-TDRD3), TOP3B (pGFP-TOP3B) and were described previously (Yang et al., 2010).
+ Open protocol
+ Expand
4

Inducible Expression of GFP-RPL3 Fusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
ORFs encoding GFP alone, or GFP fused to human RPL3, either WT or R246A/R249A-mutated (RPL3 fused to N-terminus of GFP) were cloned into the pcDNA5/FRT/TO plasmid (Thermo Fisher Scientific) under the control of a doxycycline (Dox)-inducible promoter, similarly as described in ref. (32 (link)). HEK293-derived, Flp-In™ T-REx™ 293 cells (Thermo Fisher Scientific) were co-transfected with pOG44 and pcDNA5/FRT/TO-derived plasmids, according to manufacturer's instructions, and selected with 200 μg/ml Hygromycin B (Thermo Fisher Scientific). The pool of surviving cells was maintained in high-glucose DMEM + GlutaMAX™ medium (Gibco) supplemented with 10% FBS and P/S. To test ORF expression, cells were left untreated or induced with 1 μg/ml Dox for 24 h and then fixed in cold acetone for 10 min. Cells were visualized by fluorescence microscopy after incubation with 1 μg/ml Hoechst 33258 (Sigma-Aldrich) to stain the nuclei (λex = 405 nm), similarly as described in the above section.
+ Open protocol
+ Expand
5

Generation of CDK11 Expression Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid containing human CDK11 (GenBank Accesion number: AAC72077) was obtained from Dr. J. Lahti lab (Memphis, Tennessee). CDK11 cDNA was sub-cloned into HindIII and XhoI restriction sites of doxycycline inducible pcDNA5/FRT/TO plasmid (Thermo Fisher Scientific) in frame with 5’flag or 5’myc tag. CDK11 deletion mutants were prepared using QuikChange II XL Site-Directed Mutagenesis Kit (Agilent, #200522) according to the manufacturer´s protocol. Primers for the mutagenesis were designed to flank the region to be deleted.
Complete list of plasmids used in the study is in the Supplementary Table 8
+ Open protocol
+ Expand
6

Engineered GPCR-APEX Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
pcDNA3.1/zeo/TO plasmid encoding angiotensin II type 1 receptor (AT1R) was a gift from the Lefkowitz lab (Duke University) and was used to PCR-amplify AT1R gene used for the study. β2 adrenergic receptor gene (β2AR) was PCR-amplified from the Roth Lab PRESTO-Tango GPCR Kit (Addgene). APEX2 DNA was PCR-amplified from pcDNA3 APEX2-NES, which was a gift from Alice Ting (Addgene). Each GPCR-APEX fusion protein has a C-terminal 8-residue glycine-serine linker (GGSSGGSS), followed by APEX2. β2AR-APEX also includes a Protein C affinity tag (EDQVDPRLIDGK) at the C-terminus of APEX2. All DNA constructs were cloned into pcDNA5/FRT/TO plasmid for mammalian expression (Invitrogen).
+ Open protocol
+ Expand
7

Inducible expression of FLAG-tagged γ2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length human γ2 was amplified with primers designed to encode a 5’-BamHI site and a C-terminal FLAG tag followed by an XhoI site. The resulting PCR product was cloned into the pcDNA5/FRT/TO plasmid (Invitrogen) to create pcDNA5/FRT/TO/g2. Mutagenesis of the construct was performed using the QuikChange Site-Directed Mutagenesis system (Stratagene). The plasmid (POG44) expressing Flp recombinase was from Invitrogen. T-Rex HEK-293 cells containing a single FRT site (Invitrogen) were transfected with Fugene6 (Promega) using the plasmids POG44 and pcDNA5/FRT/TO/g2 at a ratio of 9:1. Fresh medium was added to the cells 24 hours after transfection, and media containing 200 µg/ml hygromycin B and 15 µg/ml blasticidin was added 48 hours after transfection. The medium was replaced every 3 days until foci could be identified, and individual foci were then selected and expanded. The expression of FLAG-tagged g2 was induced by adding 1 µg/ml tetracycline for 40 hours, and expression detected using immunofluorescence microscopy and Western blot using anti-FLAG antibodies.
+ Open protocol
+ Expand
8

Stable Cell Line Generation for SLX9, BYSL, and RIOK1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human SLX9, BYSL, and RIOK1 cell lines were generated as described previously (17 (link),18 (link)). In brief, the coding sequences were amplified from a cDNA library. In the case of SLX9, the SLX9 gene was inserted into a modified pcDNA5/FRT/TO plasmid (Invitrogen) containing an N-terminal Strep–Flag tag followed by a 3C cleavage site (pcDNA5-N-TAP-SLX9). In the case of BYSL, the BYSL gene was inserted into a separate modified pcDNA5/FRT/TO plasmid containing a 3C-Flag-Strep at the C terminus (pcDNA5-C-TAP-BYSL). In the case of RIOK1, first, a mutation (D324A) was introduced using site-directed mutagenesis by PCR. Then, an internal Strep–Flag tag following amino acid 496 was added before insertion into the original pcDNA5/FRT/TO vector. To generate the stable cell lines, HEK Flp-In 293 T-Rex cells (Thermo Fisher, R78007) were split one day before into a 10 cm dish and grown to 50% confluence. A mixture of 0.5 μg of the plasmid, 4.5 μg of the helper pOG44 plasmid and 20 μg of polyethylenimine (PEI) was incubated for 25 min then directly added into the culture. Selection was performed with 200 μg/ml hygromycin B (Thermo Fisher) supplied in normal DMEM medium.
+ Open protocol
+ Expand
9

Lentiviral Vector for Overexpression and Deletion

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pcDNA5-FRT-TO plasmid was obtained from Invitrogen. cDNAs or sgRNAs, respectively for protein overexpression and gene deletions, were cloned in a dual promoter lentiviral vector, as described previously (van de Weijer et al., 2014 (link)).
+ Open protocol
+ Expand
10

Inducible APEX2 Fusion Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
V5-APEX2 was PCR-amplified from the pcDNA5-Mito-V5-APEX2 plasmid, which was kindly provided by Dr. Hyun-Woo Rhee (Seoul National University). V5-APEX2 alone or IPMK-V5-APEX2 were cloned into the pcDNA5/FRT/TO plasmid (Invitrogen). Flp-In T-REx–293 (Invitrogen) cells were seeded in six-well culture plates to 70% confluency, and then co-transfected with 0.25 µg of pcDNA5/FRT/TO and 2.25 µg of pOG44 Flp recombinase expression plasmid (Invitrogen) using Lipofectamine LTX with Plus Reagent (Invitrogen). After 48 hr, the cells were transferred to 90 mm culture dishes for negative selection with 50 µg/ml Hygromycin B (Gibco) until all non-transfected cells were dead. Surviving cells were seeded at low confluency to generate cellular clones on culture plates, after which each clone was individually screened for APEX2 construct expression with or without doxycycline (Sigma Aldrich) to search for optimal cell populations with minimal uncontrolled APEX2 expression and maximal APEX2 expression under stimulation. Selected clones were then expanded and stored in liquid nitrogen for downstream experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!